期刊文献+

脑白质疏松对帕金森病患者认知功能的影响 被引量:3

Influence of leukoaraiosis on the cognition of patients with Parkinson disease
原文传递
导出
摘要 目的探讨脑白质疏松(IA)对帕金森病(PD)患者认知功能的影响。方法选取确诊的PD患者63例,所有病例来自2011年9月至2012年7月安徽医科大学第一附属医院神经内科就诊患者,根据认知评分将其分为PD无认知损害组(PD-IC,n=23)、PD伴轻度认知损害组(PD-MCI,n=23)和PD痴呆组(PDD,n=17)。运用简易智能精神状态检查量表(MMSE)、剑桥老年认知量表中文版(CAMCOG-c)、临床痴呆量表(CDR)、语言流畅性测验、画钟实验(CDT)、老年抑郁量表(GDS)等对认知功能和抑郁症状进行评定;运用PD统一评分量表-运动(UPDRS-motor)和Hoehn-Yahr分期(HY)对PD运动功能进行评定;所有患者均行头颅MRI(3.0T)检查,运用Scheltens视觉评定量表评定LA的程度。结果PD-IC组[(2.43±2.79)分]和PD-MCI组[(4.48±4.33)分]的脑深部白质高信号(DHs)评分均显著低于PDD组[(7.88±6.69)分,P值分别为0.004和0.040],尤其体现在额叶[(1.09±1.31)分、(1.83±1.90)分、(3.24±2.64)分,均P〈0.05]和顶叶[(0.09±0.29)分、(0.65±1.03)分、(1.53±2.32)分,均P〈0.05],三组之间的脑室旁白质高信号(PVHs)[(1.57±1.75)分、(2.52±2.37)分、(3.24±2.64)分,均P〉0.05]、基底节[(0.09±0.42)分、(0.30±0.77)分、(0.53±1.33)分,均P〉0.05]和幕下白质高信号[(-)分、(0.13±0.63)分、(0.18±0.73)分,均P〉0.05]差异无统计学意义。DHs与年龄(P=0.003)、MMSE(P=0.009)、语言流畅性评分(P=0.009)、CAMCOG-C中的定向力(P=0.047)及执行功能(P=0.027)具有显著相关性。多元回归分析显示PD患者MMSE与文化程度(P〈0.001,B=0.600),脑深部白质(P=0.001,B=-0.678)及HY分期(P=0.035,B=-0.480)具有相关性,与脑深部白质关系最为密切。结论DHs与PD患者多个认知领域表现出相关性,尤其是执行功能;PD患者MMSE与DHs关系最为显著,DHs能够促进PD患者认知功能损害。 Objective To explore the role of leukoaraiosis (LA) on the cognitive function in patients with Parkinson disease (PD). Methods The cohort for this study included 63 patients with PD, whom were divided into 3 groups according to cognitive status : with intact cognition ( PD-IC, n = 23 ), with mild cognitive impairment (PD-MCI, n = 23) and with dementia (PDD, n = 17). All the patients were recruited from the Department of Neurology, First Affiliated Hospital, Anhui Medical University between September 2011 and July 2012. The cognitive functions were evaluated by mini-metal state examination (MMSE), the Cambridge cognitive examination-Chinese version (CAMCOG-C), clinical dementia rating (CDR), clock drawing task (CDT) and verbal fluency test, etc. Depression symptoms were assessed by the geriatric depression scale (GDS) while motor symptoms by the Unified Parkinson's Disease Rating Scale- motor (UPDRS-motor) and the Hoehn and Yahr scale(HY). All the patients underwent magnetic resonance imaging (MRI) with a 3.0-T system. LA was rated using the semiquantitative visual rating system proposed by scheltens et al. Results Both the PD-IC (2. 43±2. 79) and PD-MCI (4. 48±4. 33 ) groups showed significantly lower deep hyperintensities (DHs) scores than the PDD group (7.88 ± 6. 69, P = 0. 004 and 0. 040, respectively), especially in frontal ( 1.09 ± 1.31 ; 1.83 ± 1.90 ; 3.24 ± 2. 64, P 〈 0. 05 ) and parietal areas (0.09± 0. 29 ; 0. 65 ± 1.03 ; 1.53 ± 2. 32, P 〈 0. 05 ). There were no significant differences in periventricular ( 1.57 + 1.75 ; 2. 52 ± 2. 37 ; 3.24 ± 2. 64, P 〉 0. 05 ), basal ganglia ( 0. 09 ± 0. 42 ; 0. 30 ±0. 77 ; 0. 53 ± 1.33, P 〉0. 05) and infratentorial white matter hyperintensities scores ( -- ; 0. 13 ± 0. 63 ; 0. 18 ± 0.73, P 〉 0. 05 ) among three groups. The DHs showed a significant correlation with age( P = 0. 003 ), MMSE( P = 0. 009 ), verbal fluency test ( P = 0. 009 ), orientation ( P = 0. 047 ) and executive function ( P = 0. 027 ) in CAMCOG-C. The multiple regression analysis showed that the MMSE scores were associated significantly with education ( P 〈 0. 001,15 = 0. 600), DHs ( P = 0. 001,15 = - 0. 678 ) and HY (P = 0. 035,15 = -0. 480). DHs were the most significantly associated with MMSE scores. Conclusion There was a significant correlation between DHs and multiple domain cognitive impairment in PD, especially in executive function. DHs, which were the most significantly variable associated with MMSE scores, may contribute to cognitive impairment in PD.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第3期177-181,共5页 National Medical Journal of China
基金 安徽省教育厅自然科学基金(KJ2011A170)
关键词 帕金森病 脑白质疏松症 认知障碍 痴呆 Parkinson's disease Leukoaraiosis Cognition disorders Dementia
  • 相关文献

参考文献20

  • 1Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia inParkinson's disease: a community-based, prospective study. Neurology, 2001, 56:730-736.
  • 2Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson' s disease. Mov Disord, 2005, 20 : 1255-1263.
  • 3Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol, 1957, 44:21-23.
  • 4Burton EJ, Kenny RA, O' Brien J, et al. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke, 2004, 35:1270-1275.
  • 5张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:620
  • 6Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment:clinical characterization and outcome. Arch Neurol, 1999, 56:303-308.
  • 7Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol, 2001, 58:1985-1992.
  • 8Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord, 2007, 22 : 1689-1707 ; quiz 1837.
  • 9Scheltens P, Bark.hof F, Leys D, et al. A semiquantatave rating scale for the assessment of signal hypefintensities on magnetic resonance imaging. J Neurol Sci, 1993, 114:7-12.
  • 10Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord, 2006, 20:302-310.

二级参考文献22

  • 1Aarsland D, Andersen K, Larsen JP, et al. Risk of dementia in Parkinson' s disease: a community-based, prospective study. Neurology, 2001, 56: 730-736.
  • 2Janvin C, Aarsland D, Larsen JP, et al. Neumpsyehological profile of patients with Parkinson' s disease without dementia. Dement Geriatr Cogn Disord, 2003, 15 : 126-131.
  • 3Foltynie T, Brayne CE, Robbins TW, et al. The cognitive ability of an incident cohort of Parkinson' s patients in the UK. The CamPaIGN study. Brain, 2004, 127 Pt 3: 550-560.
  • 4Janvin CC, Larsen JP, Aarsland D, et al. Subtypes of mild cognitive impairment in Parkinson' s disease: progression to dementia. Mov Disord, 2006, 21: 1343-1349.
  • 5Caviness JN, Driver-Duncldey E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson' s disease. Mov Disord, 2007, 22 : 1272-1277.
  • 6Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol, 1999, 56: 303-308.
  • 7Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol, 2001, 58: 1985-1992.
  • 8Frisoni GB, Galluzzi S, Bresciani L, et al. Mild cognitive impairment with subeortical vascular features : clinical characteristics and outcome. J Neurol, 2002, 249 : 1423-1432.
  • 9Roth M, Tyme E, Mountioy CQ, et al. CAMDEX. A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry, 1986, 149: 698-709.
  • 10Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res, 2002, 924:113-115.

共引文献637

同被引文献49

  • 1Willis AW, Schootman M, Kung N, et al. Predictors of surviv al in patients with Parkinson'a disease. Arch Neurol, 2012, 69:601 607.
  • 2Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson'a disease co hort. Brain,2007,130:1787 1798.
  • 3Buter TC,van den Hout A,Matthews FE,et al. Dementia and survival in Parkinson's disease: a 12 year population study. Neurology, 2008,70 : 101 ? 1022.
  • 4Soriano Raya J J, Miralbell J, Lopez- Cancio E, et al. Deep ver sus periventrieular white matter lesions and cognitive function in a community sample of middle aged participants. J Int Neu ropsychol Soc,2012,18:874 885.
  • 5Manning SM, Talos DM, Zhou C, et al. NMDA receptorblockade with memantine attenuates white matter injury in a rat model of periventricu[ar leukomalacia. J Neurosci, 2008, 28:6670 6678.
  • 61.ouis ED, Brickman AM, DeCarli C, et al. Quantitative brain measurements in comnmnity-dwelling elderly persons with mild Parkinsonian signs. Arch Neurol,2008,65=1649 1654.
  • 7Lee SJ,Kim JS, Lee KS, et al. The severity of leukoaraiosis correlates with the clinical phenotype of Parkinson's disease. Arch Gerontol Geriatr, 2009,49 : 255-259.
  • 8Choi SA, Evidente VG, Caviness JN, et al. Are there differ- ences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? Acta Neuropathol, 2010,119 : 147 149.
  • 9Melzer TR, Watts R, Macaskill MR, et al. White matter mi- crostructure deteriorates across cognitive stages in Parkinson disease. Neurology, 2013,80 z 1841-1849.
  • 10Lee SJ,Kim JS,Yoo JY,et al. Influence of white matter hy perintensities on the cognition o{ patients with Parkinson dis ease. Alzheimer Dis Assoc Disord, 2010,24 : 227-233.

引证文献3

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部